Providers Infectious Diseases

Overview

Defend Against Infections with Precision Pharmacogenomics

Optimize antimicrobial therapies, reduce resistance, and streamline patient outcomes across your health system.

Overview

Infectious diseases require agile and targeted treatments to combat bacterial, viral, fungal, and parasitic pathogens—especially given rising drug resistance. PGxAI's Infectious Diseases module (PGxAegis™) integrates advanced pharmacogenomics with real-world clinical data to guide optimal drug selection and dosing for conditions ranging from common bacterial infections to complex multidrug-resistant strains. By aligning each patient's genetic profile with antimicrobial regimens, PGxAegis™ helps clinicians minimize side effects, reduce hospital stays, and improve patient recovery rates.

•

100+ essential antimicrobial drugs covered, including antibiotics, antivirals, antifungals, and antimalarials.

•

60 key genetic markers analyzed for drug metabolism, resistance profiles, and infection severity.

•

AI-driven insights updated in real time to adapt to evolving pathogens and patient-specific factors.

Key Highlights

Serving every stakeholder in healthcare

Schedule a Demo Contact Us

Broad-Spectrum Coverage

From beta-lactams to antiviral therapies like Oseltamivir, PGxAegis™ provides actionable insights across the infectious disease spectrum.

Resistance Mitigation

Genetic data helps identify potential drug resistance, guiding clinicians toward more effective, targeted therapies and prudent antibiotic stewardship.

Rapid Response

Real-time AI alerts ensure clinicians can adjust treatments quickly, reducing the risk of complications and improving outcomes.

EHR Integration

PGxAegis™ seamlessly integrates with leading EHR systems, delivering drug-gene insights within existing workflows.

Reimbursable Solutions

Built around recognized CPT codes, facilitating cost-effective and clinically validated infectious disease management.

Clinical Impact

Maximize Clinical Impact with PGXAI

Schedule a Demo Contact Us

Lower Adverse Events

Tailored regimens help reduce allergic reactions, toxicity, and drug interactions.

Improved Antibiotic Stewardship

Optimized prescribing curbs the overuse of broad-spectrum agents, aiding in the global fight against antimicrobial resistance.

Faster Recovery

Accurate drug selection from the start leads to quicker symptom resolution and shorter hospital stays.

Enhanced Quality Metrics

Reduced readmissions and complications align with value-based care initiatives, potentially boosting reimbursement rates.

Drug Categories

PGxAI supports a broad range of infectious disease therapies

Schedule a Demo Contact Us

Antibiotics:

Penicillins, Cephalosporins, Fluoroquinolones, Macrolides

Antivirals:

Oseltamivir, Acyclovir, Abacavir, Ribavirin

Antifungals:

Fluconazole, Voriconazole, Posaconazole

Antimalarials:

Chloroquine, Artemether, Primaquine

Immunomodulators:

Interferons for viral infections. Each recommendation is powered by a robust AI engine that factors in genetic variants (e.g., CYP2C19, CYP3A4), pathogen profiles, and clinical guidelines.

Integration

Seamless EHR Integration

PGxAegis™ is built to scale across multi-site health systems:

Security

HIPAA & SOC 2 compliance ensures patient privacy and data integrity.

Automations

Automated alerts for high-risk gene-drug interactions.

Analytics

Customizable dashboards for oncology pharmacists, oncologists, and care coordinators.

Case Study

Summit Infectious Disease Center

Schedule a Demo Contact Us

Challenge

Rising rates of treatment failure and antibiotic resistance in hospitalized pneumonia cases.

Solution

PGxAegis™ integrated with EHR to align each patient's antibiotic therapy with genetic susceptibility and microbial patterns.

Results

30% reduction in treatment failures over 9 months, improved resistance management, and faster patient recovery times.

"PGxAI has empowered our ID team to make proactive treatment adjustments, significantly reducing drug-resistant infections and improving patient outcomes."

Dr. Anthony Reyes

Chief Infectious Disease Specialist, Summit IDC

What's next

Ready to Shape the Future of Precision Medicine?

Empower your infectious disease teams with AI-driven pharmacogenomics that curb resistance, lower adverse events, and optimize patient recoveries.

Contact Our ID Team

Discuss pilot programs and EHR integration options.

Request a Demo

See how PGxAegis™ enhances infectious disease workflows.

Learn More About EHR Integration

Discover our secure, scalable interoperability solutions.